Stockreport

Merck Ends Revolution Medicines Talks As Oncology Plans And Valuation Weighed [Yahoo! Finance]

Revolution Medicines, Inc.  (RVMD) 
PDF Merck paused acquisition discussions with Revolution Medicines after the two sides could not agree on valuation. The halted talks highlight a shift in Merck's approac [Read more]